血液传染病检查市场按产品类型、技术、检测类型、最终用户和地区划分

预计到 2026 年，血液传染传染病检查市场价值将达到 50 亿美元，到 2033 年将达到 80.25 亿美元，2026 年至 2033 年的复合年增长率为 7%。

血液感染疾病是指血液中存在细菌、真菌或其他病原体感染的情况。这种情况通常发生在病原体经由伤口、注射或手术等途径进入血液时。血液感染疾病也称为败血症、菌血症、败血症或败血性休克。由于血液感染疾病的常见症状（如寒颤、发烧、腹泻、呕吐等）较多，因此难以自行诊断，必须进行检测才能发现血液中的感染。

市场动态

感染率的上升，包括腹部感染疾病、牙科感染疾病、肾臟和尿道感染以及慢性疾病，正在推动市场成长。根据世界卫生组织（世卫组织）统计，2016年全球有超过3,000万人感染败血症，造成600万人死亡。此外，血液传染传染病检查研发投入的增加预计也将推动市场成长。烧烫伤和创伤、爱滋病、肺炎、肾盂肾炎和癌症的高发生率，以及卫生意识的提高，预计也将推动全球血液传染传染病检查市场的成长。根据世界卫生组织（世卫组织）统计，截至2017年底，全球约有3,690万爱滋病毒感染者，2017年新增病例估计为180万例。然而，高昂的诊断成本和医疗报销不足可能会限制市场成长。

本次调查的主要特点

• 本报告对血液传染传染病检查市场进行了详细分析，以 2025 年为基准年，给出了预测期（2026-2033 年）内的市场规模和复合年增长率（%）。
• 我们将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
• 本报告根据以下参数介绍了全球血液传染传染病检查市场主要企业的概况：公司概况、财务表现、产品系列、市场地位、分销策略、主要发展、策略和未来计划。
• 本报告的研究结果将使负责人和经营团队能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
• 这份全球血液传染病检查市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过各种用于分析血液传染传染病检查市场的策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场概览

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章 市场动态、监管与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 法规环境
• 产品上市及核准情况
• PEST分析
• 波特分析
• 市场机会
• 法规环境
• 重大进展
• 产业趋势

4. 2026-2033年全球血液传染传染病检查市场（依产品类型划分）

• 装置
• 试剂和耗材
• 其他的

5. 2026-2033年全球血液传染传染病检查市场（依技术划分）

• 常规测试
• 非传统测试

6. 2026-2033年全球血液传染传染病检查市场（依检测类型划分）

• 常规血液培养检测
• PCR方法
• 核酸检测
• 质谱分析
• 就地检验

7. 2026-2033年全球血液传染传染病检查市场（依最终用户划分）

• 医院
• 独立诊断中心
• 其他的

8. 2026-2033年全球血液传染传染病检查市场（按地区划分）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第九章 竞争情势

• BioMerieux SA
• Becton
• Dickinson and Company
• AB Sciex
• IRIDICA
• Abbot Laboratories
• Cepheid Inc.
• CR Bard, Inc.
• F. Hoffmann-La Roche AG
• Nanoshpere
• Dade Behring
• AdvanDX
• Siemens Healthcare

第十章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十一章 参考文献与调查方法

• 参考
• 调查方法
• 关于本公司

Bloodstream Infection Testing Market is estimated to be valued at USD 5,000 Mn in 2026 and is expected to reach USD 8,025 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7% from 2026 to 2033.

Blood stream infection is a condition in which the blood is detected with bacterial, fungal, or any other infection. This condition normally occurs when the infection enters the blood stream of any part of body through wound, injection or during any surgical procedures. This infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult, owing to its common symptoms (such as chills, fever, diarrhea, vomiting, and others), thereby testing is mandatory for detection of infections in blood.

Market Dynamics

Increasing prevalence of infections such as abdominal infections, dental infections, kidney and urinary infection, and chronic diseases drives the market growth. According to the World Health Organization (WHO), in 2016, over 30 million people are affected by sepsis worldwide, annually, leading to 6 million deaths. Moreover, increasing R&D investments related to bloodstream infection testing is also expected to boost the market growth. Moreover, high incidences of burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along with growing awareness about hygiene is also expected to boost the global bloodstream infection testing market growth. According to World Health Organization, at the end of 2017, approximately 36.9 million people living with HIV and 1.8 million people becoming newly ininfected in 2017 globally. However, the high diagnostic costs and insufficiency medical reimbursement may hinder the market growth.

Key features of the study

• This report provides in-depth analysis of the bloodstream infection testing market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bloodstream infection testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
• Key companies covered as a part of this study include, BioMerieux SA, Becton, Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, Siemens Healthcare.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global bloodstream infection testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bloodstream infection testing market

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Instruments
  • Reagents & Consumables
  • Others
• Technology Insights (Revenue, USD Mn, 2026 - 2033)
  • Conventional Testing
  • Non-Conventional Testing
• Test Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Conventional Blood Culture Tests
  • PCR Method
  • Nucleic Acid Testing
  • Mass Spectroscopy
  • Point-Of-Care Testing
• End User Insights (Revenue, USD Mn, 2026 - 2033)
  • Hospitals
  • Independent Diagnostics Centers
  • Others
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Key Players Insights
  • BioMerieux SA
  • Becton
  • Dickinson and Company
  • AB Sciex
  • IRIDICA
  • Abbot Laboratories
  • Cepheid Inc.
  • C. R. Bard, Inc.
  • F. Hoffmann-La Roche AG
  • Nanoshpere
  • Dade Behring
  • AdvanDX
  • Siemens Healthcare

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Bloodstream Infection Testing Market, By Product Type
  • Global Bloodstream Infection Testing Market, By Technology
  • Global Bloodstream Infection Testing Market, By Test Type
  • Global Bloodstream Infection Testing Market, By End User
  • Global Bloodstream Infection Testing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Bloodstream Infection Testing Market, By Product Type, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Reagents & Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Bloodstream Infection Testing Market, By Technology, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Conventional Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Non-Conventional Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Bloodstream Infection Testing Market, By Test Type, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Conventional Blood Culture Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• PCR Method
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Nucleic Acid Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Mass Spectroscopy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Point-Of-Care Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Bloodstream Infection Testing Market, By End User, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Independent Diagnostics Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

8. Global Bloodstream Infection Testing Market, By Region, 2026 - 2033, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• BioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Sciex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IRIDICA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbot Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cepheid Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• C. R. Bard, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nanoshpere
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dade Behring
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AdvanDX
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us